series-b
Stage
1
Investors
About
NeoChord develops a medical device system for minimally invasive, beating heart repair of mitral valve regurgitation by delivering artificial chordae to restore valve function.
Explore NeoChord's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.